Skip to main content

Advertisement

Log in

Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract.

This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996. The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received 15 April and in revised form 23 June 2000

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoelzer, S., Steiner, D., Bauer, R. et al. Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Eur J Nucl Med 27, 1465–1472 (2000). https://doi.org/10.1007/s002590000333

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002590000333

Navigation